November 25, 2022
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector equities faltered Friday in a subdued trading session.
November 23, 2022
RegMed Investors’ (RMi) closing bell: gobble, gobble; share pricing heated-up
November 22, 2022
RegMed Investors’ (RMi) closing bell: cell and gene therapy companies are swing to the upside after four (4) declining sessions
November 21, 2022
RegMed Investors’ (RMi) closing bell: short, holiday interrupted week
November 18, 2022
RegMed Investors’ (RMi) closing bell: this week the cell and gene therapy sector equities got “whacked’ on the knuckles, today it got a pat on the back!
November 17, 2022
RegMed Investors’ (RMi) closing bell: skipping stones and stocks
November 16, 2022
RegMed Investors’ (RMi) closing bell: tampering and dampening share price
November 15, 2022
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector gains held fast against PPI and Poland missile strike
November 14, 2022
RegMed Investors’ (RMi) closing bell: the speed bumps slow the action
November 11, 2022
RegMed Investors’ (RMi) closing bell: closing out the week booking gains
November 10, 2022
RegMed Investors’ (RMi) closing bell: the risk-on fervor sent markets skyward and sector upward
November 9, 2022
RegMed Investors’ (RMi) closing bell: down sliding markets and sector responds to incomplete election results
November 8, 2022
RegMed Investors’ (RMi) closing bell: after five (5) down sessions, it was inevitable that the algorithms would “rule”
November 7, 2022
RegMed Investors’ (RMi) closing bell: election and economics will determine the week as negative momentum moves the sector today
November 4, 2022
RegMed Investors’ (RMi) closing bell: strolling a crooked session (10 of 35 covered companies stumbled)
November 3, 2022
RegMed Investors’ (RMi) closing bell: taking it in the shins as sector trips
November 2, 2022
RegMed Investors’ (RMi) closing bell: We waited for Jerome and got the expected .75 basis point rate increase
November 1, 2022
RegMed Investors’ (RMi) closing bell: markets dive as sector thrives, algorithms “rule’ in our favor
October 31, 2022
RegMed Investors’ (RMi) closing bell: falling and feeling more than a pinch as October ends
October 28, 2022
RegMed Investors’ (RMi) closing bell: grabbing onto the upside
October 27, 2022
RegMed Investors’ (RMi) closing bell: I told you the downdraft was coming
October 26, 2022
RegMed Investors’ (RMi) closing bell: sector slips and slides, yet with positive close
October 25, 2022
RegMed Investors’ (RMi) closing bell: the roller-coaster rides to a peak
October 24, 2022
RegMed Investors’ (RMi) closing bell: sector rains on last week’s parade
October 21, 2022
RegMed Investors’ (RMi) closing bell: no ladders needed; the tide went out and today came back in
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2022 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.